Eliem Therapeutics ELYM 深 滬
等待開盤 07-23 09:30:00 美东时间
5.11
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 5.11
- 總市值 1.41亿
- 52周最高 11.55
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 2.35
- 委 比 0.00%
- 總股本 2757.27万
- 歷史最高 29.69
- 量 比 0
- 振 幅 0.00%
- 歷史最低 2.21
- 每 手 1
- 風險率 1.17%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Climb Bio set to join Nasdaq Biotech Index
Climb Bio (NASDAQ:CLYM) said it will be added to the Nasdaq Biotech Index. The inclusion will be effective prior to market open on December 23. More on Eliem Therapeutics Eliem Therapeutics: Recent St...
2024-12-19 20:15
Climb Bio Inc. Shifts Focus to Immune-Mediated Diseases
Eliem Therapeutics, Inc. ( ($CLYM) ) has released its Q3 earnings. Here is a br...
2024-11-14 12:40
Climb Bio names Douglas Williams as chair
Climb Bio (NASDAQ:CLYM) said it has appointed Douglas Williams as its chair. Williams will succeed Andrew Levin in the role. Williams has over 30 years of executive leadership experience in the biotec...
2024-11-11 20:11
Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement
Merger to create a company focused on advancing Jade Biosciences' portfolio of ...
2024-10-31 20:38
Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining around 400 points on ...
2024-08-30 01:06
Eliem Therapeutics: Executive Changes Amid Strategic Shift
Eliem Therapeutics (ELYM) just unveiled an update. Eliem Therapeutics, Inc. has...
2024-08-28 05:48
Eliem Therapeutics Names Brett Kaplan as New COO
Eliem Therapeutics (ELYM) has shared an announcement. Eliem Therapeutics, Inc. ...
2024-08-26 19:28
快讯 | Eliem Therapeutics宣布其领导团队的新成员
Eliem Therapeutics Announces Additions to Its Leadership Team
2024-08-26 19:00
Eliem Therapeutics GAAP EPS of -$1.81
Eliem Therapeutics press release (NASDAQ:ELYM): Q2 GAAP EPS of -$1.81. Cash and cash equivalents were $223.1 million as of June 30, 2024, as compared to cash, cash equivalents, and marketable securiti...
2024-08-15 00:18
